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SUMMARY – Pleomorphic adenoma is rarely seen in childhood. After detailed literature search, 
we did not come across a case of frequent relapse of this benign tumor from childhood to adulthood. 
Th e World Health Organization defi nes relapse of pleomorphic adenoma as a histologically benign 
tumor that can have local or distant metastasis. Th ere is one hypothesis how benign tumor can metas-
tasize. According to this hypothesis, probably during the fi rst operative procedure the tissue around 
the tumor becomes permeable for tumor cells, which can lead to implantation of tumor cells into the 
surrounding tissue. In this case report, we present a case of a 30-year-old woman with pleomorphic 
adenoma of the submandibular gland, which relapsed three times. Th e patient was fi rst operated on in 
1993, at the age of 7 years. Th e fi rst two relapses occurred in 1998 and 2001, at the age of 12 and 15, 
respectively. Th e last relapse occurred in 2015, at the age of 29 years. All relapses were localized in the 
submandibular region on the right side of the neck, where the primary tumor had been operated on.
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Introduction
Tumors of salivary glands account for 1%-4% of all 
neoplastic tumors in humans. Th ese tumors are very 
rare in childhood but 35% of them are malignant. Th e 
most frequently seen tumor of salivary glands is pleo-
morphic adenoma that generally has an abundant 
amount of connective tissue and is therefore also 
named mixed tumor.
Th ese tumors are classifi ed as semi-malignant to 
make clinicians aware of their potential malignant be-
havior. Th eir multilocular structure, with fi ngerlike 
elongations, is a reason for possible tumor penetration 
into the surrounding tissue1-4.
Th e other group of tumors of salivary glands is 
metastatic pleomorphic adenoma (MPA) that, up to 
day, is still an unsolved entity. It is a histologically be-
nign tumor which may give local and distant metasta-
sis. Th e most frequent site of MPA is parotid gland 
(74%), then small salivary glands (16%) and subman-
dibular gland (10%). In the history of the disease, the 
majority of patients (81%) have at least one relapse 
before encountering distant metastasis. Bones are most 
frequently involved with metastasis (45%), followed by 
lungs (36%) and internal organs (10%). In the head 
and neck region, lymph nodes may be aff ected in 17% 
of cases. After the initial treatment of benign pleomor-
phic adenoma, MPA develops in 5 years on average, 
although metastases have been described 16, 30, or 
even 50 years after the fi rst operation. According to 
some authors, the rate of 5-year disease-free period for 
MPA is 58%5,6.
Nowadays, it is not possible to predict which be-
nign pleomorphic adenoma has metastatic potential. 
Th e use of positron emission tomography (PET) scan 
to defi ne distant metastasis or immunohistologic anal-
ysis used to predict the possible occurrence of metasta-
sis did not yield relevant clinical data due to the small 
number of patients5-8. For this reason, MPA is still 
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considered as a consequence of inadequate fi rst opera-
tion. When enucleation of the tumor was the preferred 
surgical approach, relapses were diagnosed in 20%-
45% of cases9.
Adjuvant radiotherapy and chemotherapy as pre-
ventive measures for possible relapse of the disease did 
not prove successful, and surgical treatment remains 
the fi rst option in the treatment of MPA10.
Th e paradoxical nature of MPA with its benign 
histologic characteristics and ability to give metastasis 
intrigues clinicians all over the world. Th ere are few 
hypotheses why a benign tumor may give metastasis. 
One of them is the implantation hypothesis according 
to which blood and lymph vessels become permeable 
for tumor cells, which then enter the surrounding tis-
sue. However, metastasis of pleomorphic adenoma 
found in bones and internal organs, without a history 
of previous operation of salivary glands beat the im-
plantation theory. Distant metastases are explained by 
the ability of MPA to mutate the previously accumu-
lated genetic potential. Current diagnostic methods 
cannot classify pleomorphic adenoma or identify 
which benign pleomorphic adenoma has a metastatic 
potential. Good patient history is the basis to suspect 
relapse in a patient who was treated for pleomorphic 
adenoma11-13.
Case Report
In this case report, we present a 30-year-old woman 
who had 3 relapses of pleomorphic adenoma. In 1993, 
at the age of 7 years, pleomorphic adenoma of the right 
submandibular gland was diagnosed. Extirpation of the 
whole gland with the tumor was performed. Histopath-
ologic report revealed pleomorphic adenoma, which 
was removed completely. Th e fi rst relapse occurred in 
1998, i.e. 5 years after the fi rst operation, in the region of 
surgical scar, where a nodule of 1 cm in size appeared. 
Cytologic report revealed pleomorphic adenoma. Selec-
tive supraomohyoid dissection of the neck was per-
Fig. 3. Salivary gland tissue with few nodular timorous 
sites; arrow indicating tumorous cells within nodular 
tumorous sites (HE, X200).
Fig. 2. Salivary gland tissue with few nodular tumorous 
sites; arrow indicating nodular tumorous sites (HE, 
X100).
Fig. 1. Multi-slice computed tomography scan of the neck; 
arrow indicating numerous nodose shades, 0.9-1.4 cm in 
diameter, in the right submandibular region.
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formed. Histologic examination confi rmed the nodule 
to be pleomorphic adenoma.
Th e second relapse occurred in 2001. At 1 cm deep 
to the incisional scar from the previous surgical proce-
dure, a single subcutaneous nodule was found. In the 
neck region I and II, excision of the scar and surround-
ing tissue including the subcutaneous nodule was per-
formed. Histologic examination confi rmed the nodule 
to be pleomorphic adenoma. During the next 5 years, 
the patient was regularly followed-up. Besides ultraso-
nographic examination of the neck, abdominal organs 
were also examined by ultrasound.
Th e third relapse occurred in 2012. Th e patient no-
ticed a new nodule in the scar but came to the hospital 
three years later, in 2015. In the region of the scar, a 
few nodules were present, all of them solid in consis-
tency and partially fi xed. Th e biggest nodule was 1.5 
cm in diameter. Contrast computed tomography (CT) 
of the neck region revealed a few inhomogeneous nod-
ules, 0.9-1.4 cm in diameter, in the right submandibu-
lar region (Fig. 1).
Cytological puncture confi rmed the metastasis of 
pleomorphic adenoma. Including the scars, wide re-
excision of the neck region I and II was performed. 
Macroscopically, four oval, well-formed, white nodules 
were found in the subcutaneous tissue. Th e size of the 
biggest nodule was 2.5 cm in diameter. Histologic ex-
amination confi rmed pleomorphic adenoma in all four 
nodules (Figs. 2 and 3). Ultrasound examination of the 
abdominal organs and x-ray of the lungs were normal.
Discussion
Pleomorphic adenoma with metastasis is a rare 
clinical entity, characterized by the presence of one or 
more histologically benign tumors outside the salivary 
gland. In the majority of cases, metastases are reported 
in patients that were previously operated on due to 
pleomorphic adenoma5-7. Good patient history is in-
evitable to suspect the possible metastases related to 
pleomorphic adenoma. Th e fi rst relapse can be ex-
plained by the surgical method used. As mentioned 
before, in cases of macroscopically well-defi ned tu-
mors, enuclation was the surgical procedure of choice9.
Finger-like extensions of pleomorphic adenoma, 
which are not removed during surgical procedure, are 
the most probable reason for relapse. As surgical tech-
niques have improved, enuclation technique has been 
replaced with superfi cial parotidectomy as a minimal 
surgical approach in removing pleomorphic adeno-
ma15-17.
During superfi cial parotidectomy as a surgical 
treatment of pleomorphic adenoma relapse, the tumor 
must be removed according to the accepted oncologic 
principles. Even then, the risk of relapse of the tumor 
cannot be excluded. It is explained by the hypothesis 
according to which substances excreted by the tumor 
can increase permeability of the surrounding blood 
and lymph vessels. During surgical procedure, manip-
ulation of the tumor tissue may cause tumor cells to 
enter the blood and lymph vessels5-8.
Th is hypothesis could explain the occurrence of lo-
cal, as well as distant metastasis of this tumor that is 
benign in nature. In spite of this logical explanation, 
there are reports of patients where metastases of pleo-
morphic adenoma were found in bones and/or internal 
organs, although primary tumor had not been operat-
ed on or was found after encountering metastases. 
Th ese cases were explained by the hypothesis accord-
ing to which pleomorphic adenoma could genetically 
mutate its genetic potential11-14.
Current diagnostic methods cannot predict/defi ne 
which benign pleomorphic adenoma shows aggressive 
component that can lead to development of metastasis. 
Numerous immunohistologic techniques have been 
used in an attempt to solve the unpredictable nature of 
pleomorphic adenoma, e.g., Ki-67, p53, p16, bci-2. 
Th ese immunohistologic techniques are highly im-
mune reactive in cases of malignant tumors of salivary 
glands18-21.
Due to the small number of tissue specimens taken, 
immunohistologic analysis done in order to predict the 
possible malignant nature of pleomorphic adenoma 
did not give satisfactory results. Th erefore, results of 
this procedure should be taken with caution. Analysis 
of a greater number of specimens may help understand 
the biological mechanisms and genetic mutations that 
take part in the malignant nature of benign pleomor-
phic adenoma. In spite of the achievements in modern 
medicine, patient history remains a mainstay in the 
diagnosis of MPA22,23.
It is an open question whether to tell the patient, 
especially children and their parents, about the unpre-
dictable nature of the tumor or to tell about it when 
the relapse occurs. Is it necessary to make the patient 
live with this fear for life? How long should the patient 
be followed-up?
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Although in our practice we had just one patient 
with MPA, we fi nd it worth mentioning since it was a 
case of a child that had to grow up with that disease. 
Nowadays, the majority of patients are very well self-
informed about their disease; subsequently, according 
to our opinion, there is no need to tell the patient with 
benign pleomorphic adenoma about the possible re-
lapses, which are anyhow diffi  cult to predict. Th e pa-
tient should be informed about the nature of pleomor-
phic adenoma in case of proved relapse. Th e benign 
nature of the disease should be pointed out. Further, it 
is diffi  cult to defi ne the time-line for follow up check-
ups since relapse can occur many years after the fi rst 
surgery. Individual approach to the patient, as well as 
patient age and location of relapse should be taken in 
consideration.
Conclusion
In childhood, the occurrence of pleomorphic ade-
noma is rare and relapses are really unique cases. Here, 
we present a case of pleomorphic adenoma of the sub-
mandibular gland that relapsed three times over 18 
years of the initial diagnosis. Except for good patient 
history, to date there is no proved medical approach to 
predict the possible relapse and its prevention. In the 
case of relapse of pleomorphic adenoma, the treatment 
of choice is surgery. Th e nature of the disease brings a 
dilemma whether to warn the patient about the pos-
sibility of the disease relapse or the patient should be 
told that he/she is completely cured.
According to our opinion, in such cases, the ap-
proach to the patient should be individualized. Th e 
unpredictable nature of pleomorphic adenoma and the 
possibility of relapse should only be explained to pa-
tients that experience relapse of the disease.
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RECIDIV PLEOMORFNOG ADENOMA OD DJEČJE DO ODRASLE DOBI: 
PRIKAZ SLUČAJA
S. Grabovac, Đ. Grabovac, Z. Puharić i V. Malčić Dalipi
Pleomorfni adenom u dječjoj dobi je rijedak. Pojavu višekratnih recidiva, inače dobroćudnog tumora, od dječje do odrasle 
dobi nismo našli opisanu u svjetskoj literaturi. Svjetska zdravstvena organizacija defi nira recidiv pleomorfnog adenoma kao 
histološki dobroćudan tumor koji može dati lokalne ili udaljene metastaze. Jedna od hipoteza zašto histološki dobroćudan 
tumor daje metastaze je da pri prvoj operaciji okolno tkivo postane propusno za tumorske stanice, pri čemu dolazi do 
 implantacije tumora u okolno tkivo. U radu smo opisali slučaj 30-godišnje žene kod koje je pleomorfni adenom submandi-
bularne žlijezde slinovnice recidivirao tri puta. Prvi puta je operirana 1993. u dobi od 7 godina. Recidivi tumora javili su se 
1998. i 2001. u dobi od 12 i 15 godina. Posljednji recidiv javio se 2015. godine kada je imala 29 godina. Svi recidivi bili su u 
submandibularnoj regiji desne strane vrata gdje je bio operiran primarni tumor submandibularne žlijezde slinovnice.
Ključne riječi: Adenom, pleomorfni; Submandibularna žlijezda; Tumor, recidiv, lokalni
